The barn opened as part of NC State’s TAU, the CVM’s working farm and hands-on teaching lab. 2 The new space doubles the ...

Pharmaceutical company Merck in 2020 as a result of the pandemic instituted a new policy that all international travel requires the approval of an executive at the vice president level or higher. That ...

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...

Merck lowered 2024 EPS guidance down to $7.94 to $8.03, from its previous guidance of $8.53 to $8.65. The new guidance reflects the negative impact of a one-time charge of $1.3 billion or 51 cents ...

Gnat bites can cause itching, bumps and redness on livestock. Large gnat attacks can lead to drops in production, anemia, and sometimes death of livestock and poultry. Providing shelter during active ...

Those eight strains account for roughly 30% of invasive pneumococcal disease cases in patients 65 and above, according to a ...

Ringworm is a highly contagious but easy-to-treat fungal infection spread between animals and humans, with symptoms that typically last up to 14 days. It appears on the skin, hair, and nails in humans ...

Merck's Keytruda Secures First FDA-Approval For Rare Form Aggressive Cancer The FDA has approved Merck's Keytruda (pembrolizumab) in combination with pemetrexed and platinum chemotherapy for first ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care ...

This marks Keytruda's first approval for the given indication. Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.